Spalluto G - Search Results

1

Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance.

Beani L, Bianchi C, Ferraro L, Morari M, Simonato M, Spalluto G, Tanganelli S. Beani L, et al. Among authors: spalluto g. J Pharmacol Exp Ther. 1991 Aug;258(2):472-6. J Pharmacol Exp Ther. 1991. PMID: 1650828

2

Alpha 1-adrenoreceptor-mediated increase in acetylcholine release in brain slices during morphine tolerance.

Tanganelli S, Antonelli T, Simonato M, Spalluto G, Tomasini C, Bianchi C, Beani L. Tanganelli S, et al. Among authors: spalluto g. J Neurochem. 1989 Oct;53(4):1072-6. doi: 10.1111/j.1471-4159.1989.tb07397.x. J Neurochem. 1989. PMID: 2570124

3

5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices.

Bianchi C, Ferraro L, Tanganelli S, Morari M, Spalluto G, Simonato M, Beani L. Bianchi C, et al. Among authors: spalluto g. Br J Pharmacol. 1995 Nov;116(6):2724-8. doi: 10.1111/j.1476-5381.1995.tb17233.x. Br J Pharmacol. 1995. PMID: 8590996 Free PMC article.

4

[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.

Varani K, Merighi S, Gessi S, Klotz KN, Leung E, Baraldi PG, Cacciari B, Romagnoli R, Spalluto G, Borea PA. Varani K, et al. Among authors: spalluto g. Mol Pharmacol. 2000 May;57(5):968-75. Mol Pharmacol. 2000. PMID: 10779381

5

Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.

Gessi S, Varani K, Merighi S, Morelli A, Ferrari D, Leung E, Baraldi PG, Spalluto G, Borea PA. Gessi S, et al. Among authors: spalluto g. Br J Pharmacol. 2001 Sep;134(1):116-26. doi: 10.1038/sj.bjp.0704254. Br J Pharmacol. 2001. PMID: 11522603 Free PMC article.

6

DNA minor-groove binders: results and design of new antitumor agents.

Baraldi PG, Cacciari B, Guiotto A, Romagnoli R, Zaid AN, Spalluto G. Baraldi PG, et al. Among authors: spalluto g. Farmaco. 1999 Jan-Feb;54(1-2):15-25. doi: 10.1016/s0014-827x(98)00102-5. Farmaco. 1999. PMID: 10321026 Review.

7

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists.

Baraldi PG, Cacciari B, Romagnoli R, Spalluto G, Klotz KN, Leung E, Varani K, Gessi S, Merighi S, Borea PA. Baraldi PG, et al. Among authors: spalluto g. J Med Chem. 1999 Nov 4;42(22):4473-8. doi: 10.1021/jm991114s. J Med Chem. 1999. PMID: 10579811 No abstract available.

8

A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro.

Pugliese AM, Coppi E, Spalluto G, Corradetti R, Pedata F. Pugliese AM, et al. Among authors: spalluto g. Br J Pharmacol. 2006 Mar;147(5):524-32. doi: 10.1038/sj.bjp.0706646. Br J Pharmacol. 2006. PMID: 16415905 Free PMC article.

9

Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors.

Baraldi PG, Cacciari B, Spalluto G, Ji XD, Olah ME, Stiles G, Dionisotti S, Zocchi C, Ongini E, Jacobson KA. Baraldi PG, et al. Among authors: spalluto g. J Med Chem. 1996 Feb 2;39(3):802-6. doi: 10.1021/jm950518r. J Med Chem. 1996. PMID: 8576924

10

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.

Baraldi PG, Cacciari B, Spalluto G, Pineda de las Infantas y Villatoro MJ, Zocchi C, Dionisotti S, Ongini E. Baraldi PG, et al. Among authors: spalluto g. J Med Chem. 1996 Mar 1;39(5):1164-71. doi: 10.1021/jm950746l. J Med Chem. 1996. PMID: 8676354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters